HaDEA Service contract to identify obstacles to vaccination of physical, practical or administrative nature and develop recommendations

The main objective of the ‘HaDEA Service contract to identify obstacles to vaccination of physical, practical or administrative nature and develop recommendations’ is to support EU Member States in overcoming obstacles to vaccination of physical, practical, and administrative nature, with a view to increasing vaccination coverage rates in the European Union.  

The consortium undertaking this project consists of Kantar Public, EHMA, Fundació Fisabio, ifok., the European Regional and Local Health Authorities (EUREGHA), and the European Academy of Paediatrics. 


Our consortium aims to partner with national and regional health authorities in all 27 EU Member States to complete six core tasks: 

  1. With the assistance of designated country experts, carry out a mapping of vaccination services in every EU Member State to identify obstacles to vaccination of physical, practical and administrative nature. 
  1. Conduct a large-scale survey of EU citizens and health professionals in all EU Member States to determine to what extent these obstacles have a negative impact on vaccination coverage rates. 
  1. Identify and analyse best practices developed by EU Member States to overcome these obstacles. 
  1. Organise onsite visits to the EU Member States from which best practices have been identified, to promote international knowledge-sharing and cross-pollination between health authorities. 
  1. Implement pilots of selected best practices in EU Member States to evaluate effectiveness, efficiency and transferability. 
  1. Develop final recommendations for overcoming obstacles to vaccination to present to the European Commission. 

EHMA is involved across all of these tasks and provides expertise and support on a range of activities including the recruitment and engagement of health authorities in EU Member States, the mapping of vaccination services in the EU the collection and piloting of best practices, and the development of final recommendations.  

The evidence gathered over the course of this project will be widely disseminated, including through a newly developed website which is expected to go live in early 2023, helping health managers across Europe to make informed and cost-effective decisions about vaccination. 

The project commenced in July 2022 and will continue for 3 years. 

For more information and engagement in the project, please contact  Zach Desson, Policy Manager – Health Systems